Researchers in Taiwan and Belgium developed a lab-based diagnostic workflow that could help doctors predict the severity of a ...

At 12 weeks, trofinetide-treated patients had a 5.1-point reduction in the Rett Syndrome Behaviour Questionnaire (RSBQ) scale, compared to a 1.7-point drop for those one placebo.

In a surprising twist that sounds more like science fiction than medical breakthrough, researchers have discovered that ...

Hayden Harper, a Robert. B Glenn High School senior, was selected for the new cohort of East Carolina University’s Brinkley-Lane Scholars, the university’s most prestigious scholarship. It is a ...

Broker UBS believes the three-year rout of ASX healthcare stocks is near an end and it has promoted Cochlear and Resmed to ...

Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD ...

Its new DROVE module, co-developed with Deakin University, brings smart navigation to powered ... And Neuren Pharmaceuticals (ASX:NEU) has already landed FDA approval for Rett syndrome.

Detailed price information for Thiogenesis Therapeutics Corp (TTI-X) from The Globe and Mail including charting and trades.

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program Taysha Gene Therapies, Inc.

2025 IRSF Rett Syndrome Scientific Meeting Oral Presentation Details. ... Vanderbilt Kennedy Center, Annette Schaffer Eskind Chair, Professor at the Vanderbilt University Medical Center, ...

Rett syndrome is a rare genetic neurological disorder that occurs most often in girls (1 in 10,000 births), more rarely in boys, and leads to severe impairments, ...